Abstract:Objective:To evaluate the pathological features of bilateral retinoblastoma (RB) and the relationship between different treatments and high-risk histopathologic features (HHF).Methods:Retrospective series of case studies. From 1999 to 2018, 73 patients with binocular RB diagnosed by pathological examination in Department of Ophthalmology, Peking University People's Hospital were included in the study. Among them, 50 patients were male (68.5%, 50/73), 23 patients were females (31.5%, 23/73); 11 patitents had a family history of RB. The mean age at the first diagnosis was 14.8±15.6 months. The average time between first diagnosis and first intervention was 3.97±4.74 months. According to the international classification standard of intraocular RB staging, among the 73 eyes, C, D and E stages were 2 (2.7%, 2/73), 15 (20.5%, 15/73), and 56 (76.7%, 56/73) eyes, respectively. Ocular images for each patient were obtained using a wide-angle contact fundus camera during examination under general anaesthesia. The treatment protocol (globe salvaging or enucleation) depended on the result of several clinical features. Globe salvaging treatment included chemotherapy combined with local therapy such as intra-arterial chemotherapy (IAC), intravitreal chemotherapeutics injection, cryotherapy, laser, transpupillary thermotherapy and radiotherapy. If globe salvaging failed, enucleation was offered and histopathologic analysis was conducted of the enucleated eye, the ophthalmic pathologist read and evaluated the presence of HHF. Independent samples t-test was performed to compare the continuous variables. The pathological features and the relationship between different treatments and HHF were analyzed. Group difference was calculated with chi-square. Results:Among the 73 eyes, the first treatment was enucleation in 21 eyes (28.8%, 21/73); 52 eyes (71.2%, 52/73) were treated with eye protection. After enucleation, 9 cases (12.3%, 9/73) had recurrence and metastasis, and 7 cases (9.6%, 7/73) died. The intervention time of patients with recurrence and metastasis and those without recurrence and metastasis were 7.4±7.3 and 3.5±4.1 months respectively; the first intervention time of patients with recurrence and metastasis was significantly later than that of patients without recurrence and metastasis, but the difference was not statistically significant ( t=-1.561, P=0.154). The pathological examination results showed that there were 26 eyes (35.6%, 26/73) with HHF, 4 (26.7%, 15/26) and 22 (39.3%, 22/56) eyes were in stage D and E, respectively. Those who received other treatments before enucleation had lower HHF percentages after enucleation than those who did not receive corresponding treatments, but the difference was not statistically significant ( χ2=1.852, 0.074, 0.000, 1.007, 0.007, 2.729; P>0.05). Among the 26 eyes, 5 (83.3%, 5/6) and 21 (31.3%, 21/67) eyes were treated with systemic chemotherapy combined with and without IAC, respectively, and there was a significant difference in the percentage of HHF ( χ2=4.422, P=0.035). Conclusions:IAC eye-preserving therapy before enucleation has a significant effect on HHF.

Clinical characterization and long-term postoperative outcomes of retinoblastoma patients receiving enucleation and primary orbital implantation in early infancy: an observational study

Retrospective clinical study on the comprehensive treatment of retinoblastoma

Anophthalmic Sockets in Retinoblastoma: A Single Center Experience

Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.

Quality of Life in Children with Retinoblastoma after Enucleation in China

Clinical Characteristics and Prognostic Factors of Posterior Segment Intraocular Foreign Body in a Tertiary Hospital

The Clinical Characteristics and Survival Rate of the Patients with Extraocular Retinoblastoma

Anophthalmic socket in retinoblastoma: Exploring complications and risk factors in a tertiary centre in Malaysia

Reconstruction of Anophthalmic Orbits and Contracted Eye Sockets with Microvascular Radial Forearm Free Flaps.

Orbital Development in Children with Retinoblastoma: An Imaging-Based Study

Clinical features, treatment and prognosis analysis of the asymptomatic patients with retinoblastoma

Management of orbital invasion in esthesioneuroblastoma: 14 years’ experience

Clinical Characteristics and Treatment Outcome of Children with Intraocular Retinoblastoma: A Report from A Chinese Cooperative Group

[Clinicopathologic Features of Retinoblastoma and Expression of VEGF and Ki-67 after Comprehensive Treatment].

Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy

Favorable Effects of Open Surgery on Patients with Extensive Skull Base Osteoradionecrosis Through a Personalized Sequential Approach: A Case Series

Contemporary Update of Retinoblastoma in China: Three-Decade Changes in Epidemiology, Clinical Features, Treatments, and Outcomes

Analysis of the association between different treatments and high-risk histopathologic features of bilateral retinoblastomas

Amniotic Membrane Augmentation for Enucleation After Chemotherapy in Retinoblastoma

Eye-Preserving Therapies for Advanced Retinoblastoma

Post-chemotherapy changes in retinal pigment epithelium in Retinoblastoma eyes